← Leaderboards
Philip L. Ballard
Children'S Hospital Of Philadelphia
$7,834,691
Attributed
$9,936,617
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$20,922,694 · 12
By mechanism
P50$11,968,100 · 2
R01$3,159,271 · 2
P01$2,741,496 · 2
U01$2,145,046 · 1
R21$879,681 · 2
M01$29,100 · 3
Top collaborators
- Dara Torgerson6 shared
- Roberta L Keller5 shared
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Roberta Anderson Ballard$14,822,665
- Kwaku Ohene-Frempong$11,449,096
- Beverly Banks$560
- David Schafer$560
- Pinchas Cohen$25,721,568
Others in their field
Top investigators on “Bronchopulmonary Dysplasia”
- Jacqueline Jones Coalson · Southwest Foundation For Biomedical Res$18,755,670
- Steven Herbert Abman · Johns Hopkins University$14,868,643
- Roberta Anderson Ballard · Children'S Hospital Of Philadelphia$14,356,226
- Xin Sun · University Of California, San Diego$13,989,389
- Bhagavatula Moorthy · Baylor College Of Medicine$10,829,044
- Parviz Minoo Minoo · Children'S Hospital Los Angeles$10,122,641
Research focus
Bronchopulmonary DysplasiaLungPostnatalLung DiseasesSurfactantInfantLung DevelopmentProgramsPremature InfantLung InjurySamplingClinical DataResponsePrematurePathogenesisSeveritiesAspirate SubstanceLiquid SubstanceInsightGrowthHigh RiskCohortMolecularRespiratory
Grant awards (41)
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2024 · HL · contact PI
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2023 · HL · contact PI
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2022 · HL · contact PI
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2021 · HL · contact PI
The Urinary Metabolome and Bronchopulmonary Dysplasia in Premature Infants$241,891
R21 · FY2020 · HD · contact PI
The Urinary Metabolome and Bronchopulmonary Dysplasia in Premature Infants$201,915
R21 · FY2019 · HD · contact PI
Proteomic Profile Associated with Chronic Lung Disease of Premature Infants$237,750
R21 · FY2016 · HL · contact PI
EXPRESSION AND FUNCTION OF CEACAM6 IN THE ALVEOLUS$333,239
P01 · FY2015 · HL · contact PI
Proteomic Profile Associated with Chronic Lung Disease of Premature Infants$198,125
R21 · FY2015 · HL · contact PI
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes Program$470,721
U01 · FY2014 · HL
EXPRESSION AND FUNCTION OF CEACAM6 IN THE ALVEOLUS$331,546
P01 · FY2014 · HL · contact PI
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes Program$450,967
U01 · FY2013 · HL
EXPRESSION AND FUNCTION OF CEACAM6 IN THE ALVEOLUS$365,098
P01 · FY2013 · HL · contact PI
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes Program$478,786
U01 · FY2012 · HL
EXPRESSION AND FUNCTION OF CEACAM6 IN THE ALVEOLUS$383,504
P01 · FY2012 · HL · contact PI
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes Program$514,364
U01 · FY2011 · HL
EXPRESSION AND FUNCTION OF CEACAM6 IN THE ALVEOLUS$397,129
P01 · FY2011 · HL · contact PI
Regulation and role of CEACAM6 in the lung alveolus$386,250
R01 · FY2011 · HL · contact PI
Regulation and role of CEACAM6 in the lung alveolus$386,250
R01 · FY2010 · HL · contact PI
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes Program$230,208
U01 · FY2010 · HL
Regulation and role of CEACAM6 in the lung alveolus$386,250
R01 · FY2009 · HL · contact PI
Regulation and role of CEACAM6 in the lung alveolus$385,521
R01 · FY2008 · HL · contact PI
SCOR in Pathobiology of Lung Development$1,981,931
P50 · FY2005 · HL
SURFACTANT PROTEINS AND TYPE II CELL DIFFERENTIATION$283,133
P50 · FY2005 · HL
REGULATION OF SURFACTANT PROTEIN B GENE EXPRESSION$260,015
P01 · FY2005 · HL
GENETICS OF BRONCHOPULMONARY DYSPLASIA$5,354
M01 · FY2005 · RR
GENETICS OF BRONCHOPULMONARY DYSPLASIA$645
M01 · FY2005 · RR
SCOR in Pathobiology of Lung Development$1,932,673
P50 · FY2004 · HL
Genetics of bronchopulmonary dysplasia$19,271
M01 · FY2004 · RR
Genetics of bronchopulmonary dysplasia$3,270
M01 · FY2004 · RR
SCOR in Pathobiology of Lung Development$1,895,261
P50 · FY2003 · HL
SCOR in Pathobiology of Lung Development$1,848,538
P50 · FY2002 · HL
SURFACTANT PROTEINS AND TYPE II CELL DIFFERENTIATION$243,516
P50 · FY2002 · HL
REGULATION OF SURFACTANT PROTEIN B GENE EXPRESSION$223,655
P01 · FY2002 · HL
SCOR in Pathobiology of Lung Development$1,855,659
P50 · FY2001 · HL
SURFACTANT PROTEINS AND TYPE II CELL DIFFERENTIATION$243,516
P50 · FY2001 · HL
REGULATION OF SURFACTANT PROTEIN B GENE EXPRESSION$223,655
P01 · FY2001 · HL
SCOR IN PATHOBIOLOGY OF LUNG DEVELOPMENT$1,472,015
P50 · FY2000 · HL
REGULATION OF SURFACTANT PROTEIN B GENE EXPRESSION$223,655
P01 · FY2000 · HL
SURFACTANT PROTEINS AND TYPE II CELL DIFFERENTIATION$211,858
P50 · FY2000 · HL
GENETIC VARIABILITY AND MOLECULAR ABNORMALITIES IN SURFACTANT PROTEIN DEFICIENCY$560
M01 · FY2000 · RR